Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RE: Sunblazers post #988
I realize that...just passing on some info that some may not have known...no need to be rude.
This is a good read to shed some light:
http://business.financialpost.com/investing/the-godfather-of-canadian-weed-is-digging-himself-out-of-another-sticky-situation
Look, all you guys need to take a chill pill. I know that we all have a lot of money riding on this one, and it's nerve wracking sometimes, but don't lose sight of the fact that this is a very young company...LESS THAN A YEAR OLD...and I'm sure that they are all scrambling to put things together quickly...look how far they've come already. Don't expect them to have a wonderful website, a great PR team, or all of their deals set in stone at this point. They are in a growing and evolving stage, and that is what you bought into. It's ok to question things, but try not to pick apart every little detail...have some faith. If it were my company, I'd be working my butt off to make it a success. They need your support right now, not your criticism. From what I have read, Chuck Rifici was "voted off the island" of his own company that he helped create...Tweed/Canopy...and took a few guys with him to create this company. After that experience, I'm sure they are all on a mission to show Canopy who's the best. Never underestimate the power of the human spirit...and that's why I bought into CBW.
I belong to the Cannabis Wheaton Income Corp-Investors Group on Facebook, and this is what Chuck Rifici himself posted this morning in one of the conversations about the warrant extension:
Chuck Rifici...The warrant expiry was extended 2 business days due to an error between the TSXV and our transfer agent.
Looks like they are watching and listening to us... =)
Warrant expiration extended until 2/20/2018.
https://globenewswire.com/news-release/2018/02/14/1348325/0/en/Cannabis-Wheaton-Income-Corp-Extends-Warrant-Expiry-Until-February-20-2018.html
To read more about the project and CBW's role, follow this link:
https://www.investinmj.com/directory/growers/fv-pharma-inc
FV Pharma Inc. is a private company that has partnered with CBW.
FV Pharma Intl (FVPI) is a development stage company, which engages in the distribution of teeth whitening strips in Latvia. It plans to shift its business line into the production of medical marijuana through its subsidiary.
Hope this answers your questions.
Interesting chart...shows CBW at #12 in market cap and they're less than a year old!
http://www.lbdr.co/link/MJSECTORWATCHLIST
Interesting info posted about CBW on Facebook by Jeff Khoshaba who works at KSA Capital Management in NJ. He created a model with different scenarios of CBW's projected share price in three years. To view, go to Facebook-Marajuana Stock Traders (group)-search Jeff Khoshaba in the group. Sorry, but I couldn't figure out how to link it to this board. Enjoy!
Worst Case $7.13
Conservative $12.23
Most Likely $26.23
Optimistic $54.72
"I will tell you how to become rich. Close the doors. Be fearful when others are greedy. Be greedy when others are fearful." -Warren Buffett
Volume: 5 million today! This is a Warren Buffett moment, my friends...seize the day!
Uruguay! They're playing hard ball now...can't wait to see how this all comes together!
Remember that Uruguay is the only country to date that has legalized recreational marajuana. Once Canada legalizes, they are predicting a shortage. All exports to other countries will be for medical purposes and will require a clean regulated growing environment. Even if other countries eventually legalize, Canada's industry will be far ahead of the curve.
If FV's price is going crazy, why isn't CBW's?
Here's the full story:
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S.
Century Financial Capital Group Inc. ("Century" or the "Company") and FV Pharma Inc. ("FV Pharma") are pleased to announce that they have entered into an arm's-length non-binding letter of intent dated January 12, 2018 (the "Letter of Intent") pursuant to which Century and FV Pharma propose to complete a business combination by way of three-cornered amalgamation (the "Proposed Transaction"). Following the completion of the Proposed Transaction, the resulting entity (the "Resulting Issuer") will hold all of the assets and continue the business of FV Pharma. It is anticipated that the Resulting Issuer will continue the business of FV Pharma under the name "Cannabis ConneXion Corp.".
The Letter of Intent provides that Century and FV Pharma will negotiate and enter into a definitive agreement in respect of the Proposed Transaction in February 2018 (the "Definitive Agreement"), to be completed by way of a share exchange, amalgamation, arrangement, share purchase, or other form of transaction which would result in FV Pharma becoming a wholly-owned subsidiary of Century or otherwise combine its corporate existence with a wholly-owned subsidiary of Century. Once the Proposed Transaction structure is determined, the Letter of Intent will be superseded by the Definitive Agreement.
There are a number of conditions precedent to the completion of the Proposed Transaction for both Century and FV Pharma, including, but not limited to: completion of the Definitive Agreement; completion of the FV Pharma Financing (as defined herein), completion of satisfactory due diligence; shareholder approval of the articles of amendment of Century and the Proposed Transaction (if required); and receipt of all necessary regulatory approvals.
Prior to consummation of the Proposed Transaction, it is anticipated that, (A) Century will, subject to the approval of Century Shareholders, file articles of amendment to amend its authorized shares as follows: (i) amend and designate the current Century common shares as Class B subordinate voting shares ("Century Class B Shares"), with terms and conditions similar to the existing Class "B" Common Shares of FV Pharma ("FV Pharma Class B Shares"); and (ii) create a new class of Class A multiple voting shares ("Century Class A Shares") with terms and conditions similar to the existing Class "A" Common Shares of FV Pharma ("FV Pharma Class A Shares"); (B) FV Pharma will complete a brokered private placement of subscription receipts for a minimum aggregate gross proceeds of C$14,000,000 (the "FV Pharma Financing"), for which First Republic Capital Corporation will act as exclusive lead agent; and (C) the Resulting Issuer will change its name to "Cannabis ConneXion Corp.", or such other name as the parties may agree.
Pursuant to the Proposed Transaction, Century will purchase all of the FV Pharma Class B Shares in exchange for Century Class B Shares issued from treasury, and all of the FV Pharma Class A Shares in exchange for Century Class A Shares issued from treasury. Holders of FV Pharma Class B Shares will receive one Century Class B Share for each one FV Pharma Class B Share held, resulting in the issuance of approximately 763,562,145 Century Class B Shares at a deemed issued price of $0.09 per Century Class B Share, and holders of FV Pharma Class A Shares will receive one Century Class A Share for each one FV Pharma Class A Share held, resulting in the issuance of 15,000 Century Class A Shares, all for aggregate ascribed value of approximately $70 million.
Following the completion of the Proposed Transaction, the resulting issuer is expected to carry on the business of FV Pharma which is described below.
FV Pharma and Century intend on applying to the Canadian Securities Exchange ("CSE") to qualify the listing of the Resulting Issuer Class B Shares on the CSE. There is no assurance the CSE will provide conditional or final approval of the application to list the Resulting Issuer Class B Shares on the CSE. The CSE has not reviewed or provided comments on the Proposed Transaction. The CSE's final approvals remain subject to fulfilling all of the requirements of the CSE. It is currently contemplated that the Resulting Issuer will trade under the stock ticker "HUGE".
Does anyone know anything about this?
First the original announcement...
Dec. 21, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. is pleased to announce that it has entered into a letter of intent (the “Agreement”) with FV Pharma Inc.
The Transaction remains subject to certain conditions precedent including receipt of applicable regulatory approvals including Health Canada approval and the execution of a definitive agreement which the parties expect to occur within 45 days.
And now this...
Century Financial Capital Group Inc. ("Century" or the "Company") and FV Pharma Inc. ("FV Pharma") are pleased to announce that they have entered into an arm's-length non-binding letter of intent dated January 12, 2018 (the "Letter of Intent") pursuant to which Century and FV Pharma propose to complete a business combination by way of three-cornered amalgamation (the "Proposed Transaction"). Following the completion of the Proposed Transaction, the resulting entity (the "Resulting Issuer") will hold all of the assets and continue the business of FV Pharma. It is anticipated that the Resulting Issuer will continue the business of FV Pharma under the name "Cannabis ConneXion Corp.".
Chuck Rifici, a true pioneer of the North American cannabis industry and the CEO of Nesta Holding Co. explores product branding, production and discovery in the final days of Canadian prohibition.
Everyone needs to relax on this one. You are investing in a very young company that is in a hyper growth stage. They have a strong vision, experienced management, and are making all the right moves. As for dilution, they are borrowing against the house right now to position themselves quickly. Buy what you can under $2, and then wait and watch during the next few years when the profits start rolling in...Rome wasn't built in a day!